621
Participants
Start Date
May 31, 2004
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
Lacosamide
50 to 100 mg Lacosamide film-coated tablets; two times per day up to 600 mg/day; 6.5 years
180, Vienna
183, Vienna
003, Antwerp
006, Bonheiden
002, Genk
001, Leuven
005, Merksem
004, Roeselare
011, Pleven
014, Plovdiv
017, Plovdiv
019, Rousse
012, Sofia
013, Sofia
015, Sofia
016, Sofia
210, Stara Zagora
010, Varna
028, Brno
220, Chomutov
026, Litoměřice
027, Olomouc
024, Ostrava-Poruba
029, Písek
021, Prague
022, Prague
192, Kuopio
034, Lisieux
031, Nevers
040, Bad Saarow
052, Beckum
049, Berlin
051, Berlin
056, Berlin
242, Berlin
249, Berlin
247, Bochum
041, Hamburg
045, Hamburg
054, Hamburg
244, Jena
058, Köthen
043, Künzing
050, Leipzig
053, Leipzig
250, Leipzig
046, Mittweida
243, München
246, Schwerin
044, Stuhr-Brinkum
248, Witten
060, Budapest
062, Budapest
061, Győr
262, Kecskemét
260, Makó
266, Nyíregyháza
064, Szeged
265, Székesfehérvár
264, Szolnok
263, Tatabánya
261, Veszprém
270, Pavia
273, Pavia
272, Pozzilli
092, Bialystok
293, Bialystok
094, Bydgoszcz
095, Częstochowa
091, Gdansk
093, Gdansk
294, Krakow
297, Krakow
090, Lodz
295, Lodz
291, Radom
292, Warsaw
296, Warsaw
290, Ząbkowicki
100, Bucharest
102, Bucharest
107, Bucharest
108, Bucharest
109, Bucharest
101, Cluj-Napoca
103, Timișoara
114, Moscow
115, Moscow
116, Moscow
112, Saint Petersburg
111, Samara
140, Belgrade
143, Belgrade
144, Belgrade
142, Niš
137, Granada
159, Bath
154, Bristol
152, Leeds
150, Morriston
151, Newport
Lead Sponsor
UCB Pharma
INDUSTRY